DexCom, Inc. (DXCM) key performance indicators and operating metrics (8 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Earnings per Share (Non-GAAP), Diluted | 0.56 USD_per_share | FY2026-Q1 |
| Gross Profit Margin (GAAP) | 62.90 percent | FY2026-Q1 |
| Gross Profit Margin (Non-GAAP) | 63.50 percent | FY2026-Q1 |
| Operating Income (Non-GAAP as Presented) | 264.4M | FY2026-Q1 |
| Gross Profit (Non-GAAP as Presented) | 757.4M | FY2026-Q1 |
| Net Income (Non-GAAP) | 216.3M | FY2026-Q1 |
| Organic Revenue | 1.17B | FY2026-Q1 |
| Operating Profit Margin (GAAP) | 25.60 percent | FY2025-Q4 |
Back to DXCM overview · DXCM earnings · DXCM holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.